Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 21820471)

1.

Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay.

Zhou Y, Agudelo J, Lu K, Goetz DH, Hansell E, Chen YT, Roush WR, McKerrow J, Craik CS, Amberg SM, Simmons G.

Antiviral Res. 2011 Nov;92(2):187-94. doi: 10.1016/j.antiviral.2011.07.016. Epub 2011 Jul 26.

2.

Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.

Kuhn JH, Li W, Radoshitzky SR, Choe H, Farzan M.

Antivir Ther. 2007;12(4 Pt B):639-50. Review.

PMID:
17944271
3.

Antiviral drugs specific for coronaviruses in preclinical development.

Adedeji AO, Sarafianos SG.

Curr Opin Virol. 2014 Oct;8:45-53. doi: 10.1016/j.coviro.2014.06.002. Epub 2014 Jul 2. Review.

PMID:
24997250
4.

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.

Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Review.

5.

SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.

Sims AC, Burkett SE, Yount B, Pickles RJ.

Virus Res. 2008 Apr;133(1):33-44. Epub 2007 Apr 23. Review.

6.

An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.

Chen S, Luo H, Chen L, Chen J, Shen J, Zhu W, Chen K, Shen X, Jiang H.

Curr Pharm Des. 2006;12(35):4539-53. Review.

PMID:
17168760
7.

Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors.

Kilianski A, Baker SC.

Antiviral Res. 2014 Jan;101:105-12. doi: 10.1016/j.antiviral.2013.11.004. Epub 2013 Nov 20. Review.

8.

Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.

Yeung KS, Meanwell NA.

Infect Disord Drug Targets. 2007 Mar;7(1):29-41. Review.

PMID:
17346209
9.

Anti-SARS coronavirus agents: a patent review (2008 - present).

Kumar V, Jung YS, Liang PH.

Expert Opin Ther Pat. 2013 Oct;23(10):1337-48. doi: 10.1517/13543776.2013.823159. Epub 2013 Aug 2. Review.

PMID:
23905913
10.

Drug design targeting the main protease, the Achilles' heel of coronaviruses.

Yang H, Bartlam M, Rao Z.

Curr Pharm Des. 2006;12(35):4573-90. Review.

PMID:
17168763
11.

Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.

Yeung KS, Yamanaka GA, Meanwell NA.

Med Res Rev. 2006 Jul;26(4):414-33. Review.

PMID:
16521129
12.
13.

Therapies for coronaviruses. Part I of II -- viral entry inhibitors.

Tong TR.

Expert Opin Ther Pat. 2009 Mar;19(3):357-67. Review.

PMID:
19449500
14.

Development of antiviral therapy for severe acute respiratory syndrome.

Cinatl J Jr, Michaelis M, Hoever G, Preiser W, Doerr HW.

Antiviral Res. 2005 Jun;66(2-3):81-97. Epub 2005 Apr 26. Review.

PMID:
15878786
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk